-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RqwcJnIz9wej3+Ra9Drl/eCtDTAKV/dBSUNk4gQ91qQibggHh+8i0S9IhB02bBTM 8+RDUNV4G9GZrGQtsen0tw== 0000109657-07-000044.txt : 20071113 0000109657-07-000044.hdr.sgml : 20071112 20071113144831 ACCESSION NUMBER: 0000109657-07-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071109 FILED AS OF DATE: 20071113 DATE AS OF CHANGE: 20071113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6502122568 MAIL ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REPINE JOHN E CENTRAL INDEX KEY: 0001067191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 071237204 BUSINESS ADDRESS: BUSINESS PHONE: 3036501200 MAIL ADDRESS: STREET 1: 6850 N BROADWAY SUITE G CITY: DENVER STATE: CO ZIP: 80221 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2007-11-09 0 0000109657 OXIS INTERNATIONAL INC OXIS.OB 0001067191 REPINE JOHN E 6850 N BROADWAY SUITE G DENVER CO 80221 1 0 0 0 Non-Qualified Stock Option (right to buy) 0.1 2007-11-09 4 A 0 5000 0 A 2008-11-09 2017-11-08 Common Stock 5000 482187 D Michael Espey, Attorney-in-fact for John E Repine 2007-11-13 -----END PRIVACY-ENHANCED MESSAGE-----